ArticleInternational archives of allergy and immunology2026
Efficacy of Abrocitinib and Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals Recommended by Experts in China.
Zuotao Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.